Persistence and adverse events of biological treatment in adult patients with juvenile idiopathic arthritis: results from BIOBADASER

Persistence and adverse events of biological treatment in adult patients with juvenile idiopathic arthritis: results from BIOBADASER

Abstract Background Biologic therapy has changed the prognosis of patients with juvenile idiopathic arthritis (JIA). The aim of this study was to examine the pattern of use, drug survival, and adverse events of biologics in patients with JIA during the period from diagnosis to adulthood. Methods All...

Full description

Bibliographic Details
Main Authors: Juan José Bethencourt Baute, Carlos Sanchez-Piedra, Dolores Ruiz-Montesinos, Marta Medrano San Ildefonso, Carlos Rodriguez-Lozano, Eva Perez-Pampin, Ana Ortiz, Sara Manrique, Rosa Roselló, Victoria Hernandez, Cristina Campos, Agustí Sellas, Walter Alberto Sifuentes-Giraldo, Javier García-González, Fernando Sanchez-Alonso, Federico Díaz-González, Juan Jesús Gómez-Reino, Sagrario Bustabad Reyes, on behalf of the BIOBADASER study group
Format: Article
Language:English
Published: BMC 2018-10-01
Series:Arthritis Research & Therapy
Subjects:
Juvenile idiopathic arthritis
Biologic treatment
Safety therapy
Clinical practice
Online Access:http://link.springer.com/article/10.1186/s13075-018-1728-3

Internet

http://link.springer.com/article/10.1186/s13075-018-1728-3

Similar Items